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Hypoxia inducible factor-1 (HIF-1) initiates key cellular and tissue responses to physiological and pathological hypoxia. Evidence from in vitro
and structural analyses supports a critical role for Cited2 in down-regulating HIF-1-mediated transcription by competing for binding with oxygen-
sensitive HIF-1α to transcriptional co-activators CBP/p300. We previously detected elevated expression of HIF-1 target genes in Cited2−/−
embryonic hearts, indicating that Cited2 inhibits HIF-1 transactivation in vivo. In this study, we show for the first time that highly hypoxic cardiac
regions in mouse embryos corresponded to the sites of defects in Cited2−/− embryos and that defects of the outflow tract, interventricular septum,
cardiac vasculature, and hyposplenia were largely rescued by HIF-1α haploinsufficiency. The hypoxia of the outflow tract and interventricular
septum peaked at E13.5 and dissipated by E15.5 in wild-type hearts, but persisted in E15.5 Cited2−/− hearts. The persistent hypoxia and abnormal
vasculature in the myocardium of interventricular septum in E15.5 Cited2−/− hearts were rescued with decreased HIF-1α gene dosage.
Accordingly, mRNA levels of HIF-1-responsive genes were reduced in Cited2−/− embryonic hearts by HIF-1α heterozygosity. These findings
suggest that a precise level of HIF-1 transcriptional activity critical for normal development is triggered by differential hypoxia and regulated
through feedback inhibition by Cited2.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cited2; Hypoxia; Vascular endothelial growth factor-A; Heart developmentIntroduction
Hypoxia-inducible factor-1 (HIF-1) has fundamental func-
tions in mammalian development and homeostasis and is
considered a target for therapy in cancer and cardiac ischemia
(Semenza, 2003). It is activated in response to localized tissue
hypoxia to regulate transcription of more than 70 hypoxia-
inducible genes that mediate angiogenesis, erythropoiesis,⁎ Corresponding authors. Y.-C. Yang is to be contacted at fax: +1 216 368
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doi:10.1016/j.ydbio.2006.08.072vasodilation, and anaerobic metabolism (Iyer et al., 1998).
Under normoxic conditions, the HIF-1α subunit is rapidly
degraded and transcriptionally repressed. In response to a
hypoxic stimulus, HIF-1α protein is stabilized in the
cytoplasm and translocates into the nucleus, where it
dimerizes with the constitutively expressed HIF-1β subunit
(Jiang et al., 1996). The heterodimer HIF-1 then binds
hypoxia response elements within the regulatory regions of a
variety of target genes to modulate their expression through
the recruitment of transcriptional coactivators such as CBP,
p300, and SRC-1 (Semenza, 2002).
The positive regulation of HIF-1 activity has been the focus
of much research. An important but less studied aspect,
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activity. Cited2 [cAMP-responsive element-binding protein
(CBP)/p300-interacting transactivators with glutamic acid (E)
and aspartic acid (D)-rich tail 2], a HIF-1-inducible gene, has
been shown to negatively regulate hypoxia-mediated signaling
by competing with HIF-1α in binding to the CH1 region of
CBP/p300 in vitro (Bhattacharya et al., 1999; Freedman et al.,
2003). This is a unique feedback regulatory mechanism to
limit excess HIF-1 activation and to maintain normal tissue
homeostasis. Cited2 expression can also be regulated by other
factors including cytokines, lipopolysaccharide, and shear
stress (Bhattacharya et al., 1999; Sun et al., 1998; Yokota et
al., 2003), which underscores its involvement in many
physiological processes. Cited2 is specifically expressed in
the anterior visceral endoderm during early mouse and chicken
development (Dunwoodie et al., 1998; Schlange et al., 2000).
Its expression persists in the rostral mesoderm as it is
translocated caudalwards during the invagination of the
foregut and the formation of the heart and is largely restricted
to the outflow and inflow regions of the heart, atrioventricular
cushion, septum primum, and the crest and apex of the
muscular ventricular septum by E13.5 (Dunwoodie et al.,
1998; Schlange et al., 2000; Weninger et al., 2005). These
expression patterns suggest an important role for Cited2 in
tissues that contribute directly and indirectly to early and later
steps in cardiac development.
Cited2-deficient embryos on the mixed genetic background
exhibit numerous developmental defects, including cardiac
malformations, adrenal agenesis, neural crest defects, and
exencephaly (Bamforth et al., 2001; Barbera et al., 2002; Yin
et al., 2002). Cardiac defects in Cited2−/− embryos included
double outlet right ventricle, atrial septal defect (ASD),
ventricular septal defect (VSD), overriding aorta, persistent
truncus arteriosus, and pulmonary artery stenosis. These defects
can be attributed to the loss of at least three Cited2 functions: (1)
Cited2 is a co-activator of Tfap2 that is important for neural
crest cell development and in its absence transactivation by
Tfap2 is defective (Bamforth et al., 2001); (2) Cited2 is a
negative regulator for HIF-1 and in its absence VEGF-A is
overexpressed in the heart (Yin et al., 2002); (3) Cited2 is
required for the establishment of the left–right axis in mouse
development through a Nodal-Pitx2c pathway and in its
absence left–right asymmetry is abnormal (Bamforth et al.,
2004; Weninger et al., 2005). Recently, 3 Cited2 mutations, all
of which significantly reduced the capacity of Cited2 to
transrepress HIF-1 with one also resulting in significantly
diminished Tfap2c co-activation, were found in 392 patients
with congenital heart defects (Sperling et al., 2005). The aim of
this study was to determine which defects in the Cited2−/−
embryos could be attributed to the loss of Cited2 as a negative
feedback regulator of HIF-1-mediated transcription.
In this study, we show that malformations of the outflow tract
(OFT) and interventricular septum (IVS) and hyposplenia in
Cited2−/− embryos could be rescued by HIF-1α haploinsuffi-
ciency. We also show that there was a peak of hypoxia and HIF-
1α nuclear localization in specific regions of mouse embryonic
heart including the OFT and IVS where Cited2 expression wasdetected in a critical stage of OFT and IVS development.
Hypoxia in the myocardium of the OFT and IVS detected by
EF5 and HIF-1α immunostaining diminishes by E15.5 after the
coronary vasculature has connected to the aortic root. In
contrast, in the E15.5 Cited2-deficient hearts, both hypoxic
markers continue to intensely stain the OFT and IVS.
Furthermore, HIF-1α heterozygosity rescued the excessive
hypoxia, VEGF-A overexpression, abnormal coronary vascu-
lature, and defective myocardium at these sites in E15.5
Cited2−/− hearts. These data suggest that Cited2 performs an
essential role as a feedback regulator of HIF-1 activity during
development of the cardiac OFT and IVS, thus preventing
abnormal and ineffective coronary vascularization likely due to
excessive VEGF-A production.
Materials and methods
Mouse strains and generation
Cited2+/− and HIF-1α+/− mice were genotyped by Southern blot analyses
(Iyer et al., 1998; Yin et al., 2002). The Cited2+/− mice were backcrossed 12
generations into C57BL/6J genetic background before embryonic lethality was
investigated. Cited2+/−;HIF-1α+/−mice were generated by crossing the Cited2+/−
mice on the C57BL/6J genetic background with HIF-1α+/− mice on the
129SV×C57BL/6J genetic background. Cited2−/−;HIF-1α+/− and Cited2−/−;
HIF-1α+/+ embryos were obtained from the intercrosses between the Cited2+/−;
HIF-1α+/− mice and Cited2+/− mice.
Embryonic histology and immunohistochemistry and EF5 injection
Embryos were harvested from timed matings, fixed in 4% paraformalde-
hyde, and embedded in paraffin. Hematoxylin and eosin (HE) stained sections
were used for histological examination. Pregnant heterozygotes were injected
with 10 mM EF5, 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropro-
pyl)-acetamide, at 1% of body weight. Three hours later, the embryos were fixed
in 4% paraformaldehyde. EF5 staining, which has been described previously
(Sugishita et al., 2004a,b), was performed on 10-μm cryosections from 3 each
of E11.5, E13.5, and E15.5 wild-type, Cited2−/−;HIF-1α+/+, and Cited2−/−;
HIF-1α+/− hearts including at least 1 set of wild-type, Cited2−/−;HIF-1α+/+, and
Cited2−/−;HIF-1α+/− littermates at each stage by using a mouse monoclonal anti-
EF5 Cy3-conjugated antibody (ELK-51 from Dr. Cameron Koch at University
of Pennsylvania). Immunohistochemistry was carried out on 10-μm cryosec-
tions by using rabbit polyclonal anti-HIF-1α (1:200 dilution), anti-VEGF-A
(1:100 dilution, BD PharMingen, San Diego, CA), anti-CD31 (1:200 dilution,
BD PharMingen), and anti-myosin heavy chain (MF20, 1:50 dilution,
Developmental Studies Hybridoma Bank) antibodies on 10-μm cryosections.
Anti-CD31 reaction was detected by the Labeled Streptavidin Biotin Kit (Dako,
Carpinteria, CA). The others were detected with appropriate secondary
antibodies conjugated with biotin (1:200 dilution, Vector, Burlingame, CA),
and the signal was amplified with fluorescein tyramide signal (Perkin Elmer,
Boston, MA).
Real-time RT-PCR
Ventricles from embryos at E15.5 were dissected, frozen, and stored until
embryonic DNA was genotyped. Ventricles from 5 each of E15.5 wild-type,
Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− hearts, including 3 sets of wild-
type, Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− littermate hearts, were used
for RNA extraction. Total RNAwas isolated using Trizol reagent and 5 μg total
RNA was used for cDNA synthesis using the SuperScriptTM First Strand
Synthesis System (Invitrogen, Carlsbad, CA). Real-time PCR reactions were
carried out with diluted RT reaction products using iQTM SYBR Green
Supermix PCR kit and iCycler machine (Bio-Rad). β-actin transcript was used
as an internal control for normalization.
Table 2
Phenotypes of Cited2−/−;HIF-1α+/+ and Cited2−/−;HIF-1α+/− embryos at E18.5
on the mixed background
Cited2−/−;
HIF-1α+/+
Cited2−/−;
HIF-1α+/−
Ventricular septal defect 6/6 2/8
Overriding aorta or smaller diameter aorta 6/6 0/8
Double-outlet right ventricle 4/6 0/8
Atrial septal defect 5/6 3/8
Right atrial isomerism 1/6 2/8
Right pulmonary isomerism 1/6 2/8
Hyposplenia 6/6 0/8
Adrenal agenesis 6/6 8/8
Exencephaly 6/6 7/8
132 B. Xu et al. / Developmental Biology 301 (2007) 130–140Coronary vascular permeability measured by Evans blue dye
Extravasation of Evans blue dye (EBD) identifies increased vascular
permeability and/or disruption of endothelial integrity. Embryos at E15.5 were
injected with 10 mg/ml EBD (Sigma, St Louis, MO) in umbilical veins
immediately after dissection (Supplemental Fig. 1). To evaluate the coronary
vascular permeability, the level of the extravasation of albumin-bound EBD in
the embryonic heart tissue was measured (Thurston et al., 1999). To further
examine which specific regions in the embryonic hearts have accumulated EBD,
embryos were fixed in 4% paraformaldehyde and cryosections were observed by
fluorescence microscope (Shai et al., 2002).
Statistical analysis
Statistical difference between two independent groups was assessed by
Fisher's Exact test or Independent-samples t test; p≤0.05 was considered
statistically significant.Results
Embryonic lethality and defects in Cited2−/− embryos on the
C57BL/6J genetic background
Previous studies showed that Cited2-null embryos die at
late gestation and display numerous developmental defects on
both mixed 129SV×C57BL/6J and pure C57BL/6J genetic
backgrounds (Bamforth et al., 2001, 2004; Barbera et al.,
2002; Yin et al., 2002; Weninger et al., 2005). In this study,
Cited2-null embryos on the C57BL/6J genetic background
died from E15.5 (Table 1). Twelve Cited2−/− embryos
between E14.5 and E17.5 examined by HE-stained transverse
sections had cardiac malformations, adrenal agenesis, hypos-
plenia, exencephaly as well as left–right patterning defects
(Supplemental Fig. 2). All of the 12 Cited2−/− embryos had
adrenal agenesis, hyposplenia, and cardiac defects including
ASD, VSD, overriding aorta, double-outlet right ventricle,
and persistent truncus arteriosus in different combinations.
The left–right patterning defects including abnormal heart
looping, right-sided aortic arches, ASDs with right atrial andTable 1
Cited2 genotype of embryos from Cited2+/− intercrosses and Cited2+/− and
Cited2+/−/HIF-1α+/− intercrosses
Intercrosses Stage Embryo no.
+/+ +/− −/−
Cited2+/−×Cited2+/− E11.5 9 14 7
Cited2+/−×Cited2+/− E12.5 11 24 9
Cited2+/−×Cited2+/− E13.5 6 12 5
Cited2+/−×Cited2+/− E14.5 13 45 10
Cited2+/−×Cited2+/− E15.5 9 21 6
Cited2+/−×Cited2+/− E16.5 13 16 7
Cited2+/−×Cited2+/− E17.5–18 28 69 9
Cited2+/−×Cited2+/−;HIF-1α+/− E13.5 10 22 12 (6+6) a
Cited2+/−×Cited2+/−;HIF-1α+/− E15.5 12 26 10 (4+6) b
Cited2+/−×Cited2+/−;HIF-1α+/− E17.5–18.5 55 112I 22 (6+16) c
Cited2+/−×Cited2+/−;HIF-1α+/− PD10 10 26 0
PD: postnatal day.
a 6 Cited2−/−;HIF-1α+/+ and 6 Cited2−/−;HIF-1α+/− embryos.
b 4 Cited2−/−;HIF-1α+/+ and 6 Cited2−/−;HIF-1α+/− embryos.
c 6 Cited2−/−;HIF-1α+/+ and 16 Cited2−/−;HIF-1α+/− embryos.pulmonary isomerism, and stomachs lying in the midline were
observed in 7 of 12 Cited2−/− embryos. These results suggest
that the role of Cited2 in establishing embryonic laterality
may not be the only mechanism to account for the
cardiovascular malformations in the Cited2-null embryos.
HIF-1α heterozygosity rescued the cardiac OFT and
ventricular septum defects and hyposplenia in Cited2−/−
embryos
In vitro data and gene-targeting results support that the car-
diac defects in Cited2−/− embryos may be mediated by the
dysregulated expression of HIF-1 target genes (Bhattacharya et
al., 1999; Yin et al., 2002). To test the consequences to morpho-
genesis of varying gene dosages of Cited2 and HIF-1α, mice
doubly heterozygous for Cited2 and HIF-1α were generated.
These double heterozygotes and Cited2+/+;HIF-1α+/− mice
survived with the expected Mendelian ratio. From the intercros-
ses between the Cited2+/−;HIF-1α+/− mice and Cited2+/− mice,
no Cited2−/−;HIF-1α+/− mice survived to birth (Table 1). The
ratio of Cited2−/−;HIF-1α+/+ embryos to Cited2−/−;HIF-1α+/−
embryos was almost 1 to 1 at E13.5 and E15.5 (E13.5: 6/6;
E15.5: 4/6), but 1 to 2.7 (6/16) at E17.5–18.5 (Table 1),
indicating that Cited2−/−;HIF-1α+/− embryos survived longer
than Cited2−/−;HIF-1α+/+ embryos. All of the six Cited2−/−;
HIF-1α+/+ and 8 Cited2−/−;HIF-1α+/− embryos at 18.5 d.p.c.,
including 2 pairs of Cited2−/−;HIF-1α+/+ and Cited2−/−;
HIF-1α+/− littermates, were examined by HE-stained transverse
sections and their phenotypes were summarized in Table 2.
Notably, the VSD (Figs. 1a: A–C), overriding aorta or
smaller diameter aorta compared with pulmonary artery (Figs.
1a: D–I), and double-outlet right ventricle (Figs. 1a: D–F)
observed in Cited2−/−;HIF-1α+/+ embryos were absent in 6 out of
8 Cited2−/−;HIF-1α+/− embryos (p=0.009). Small membranous
VSDs were identified in the other 2 Cited2−/−;HIF-1α+/−
embryos (data not shown). ASD was observed in 5 Cited2−/−;
HIF-1α+/+ embryos, 2 Cited2−/−;HIF-1α+/− embryos that also
had right atrial and pulmonary isomerism, and 1 Cited2−/−;HIF-
1α+/− embryo that did not have right atrial and pulmonary
isomerism (Figs. 1a: J–L). Fig. 1b is a diagram depicting the
levels of heart sections in A–L. Hyposplenia was detected in 6
Cited2−/−;HIF-1α+/+ embryos, but the size of the spleens was
normal in all 8 Cited2−/−;HIF-1α+/− embryos (Supplemental
Fig. 1. Rescue of OFT and ventricular septum defects in Cited2−/− embryos by HIF-1α haploinsufficiency. (a) HE-stained transverse sections from wild-type (A, D, G,
J), Cited2−/−;HIF-1α+/+ (B, E, H, K), and Cited2−/−;HIF-1α+/− (C, F, I, L) embryos at E18.5. Caudal-to-cranial series from representative wild-type embryos showed
normal IVS (A), right ventricular OFT (D, J), aorta (D, G, J), pulmonary artery (G), and interatrial septum (IAS) (J). Caudal-to-cranial series from Cited2−/−;HIF-1α+/+
embryos exhibited VSD (B), aortic trunk arising from the right ventricular OFT (E), the smaller diameter of the aorta compared to the pulmonary artery (H), and ASD
(K). Caudal-to-cranial series from Cited2−/−;HIF-1α+/− embryos displayed normal IVS (C), right ventricular OFT (F, L), aorta (F, I, L), and pulmonary artery (I) but an
ASD (L). (b) A diagram of a normal heart showing different levels of sections A–L. AO: aorta; IAS: interatrial septum; PA: pulmonary artery; RV: right ventricle; LV:
left ventricle; RA: right atrium; LA: left atrium.
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adrenal agenesis, exencephaly, and left–right patterning defects
in Cited2−/− embryos. These histological results suggest that
reducing the gene dosage of HIF-1α can rescue the OFT and
ventricular septum defects in Cited2-deficient embryos irre-
spective of the presence of the left–right asymmetry defects.
Hypoxic regions and relative hypoxic levels in wild-type,
Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− mouse
embryonic hearts
HIF-1 mediates changes in gene expression in response to
lowered oxygen levels. The accumulation of EF5, a metabolic
indicator of hypoxia (Koch, 2002), was used to identify hypoxic
regions in 3 each of wild-type, Cited2−/−;HIF-1α+/+, and
Cited2−/−;HIF-1α+/− mouse hearts at E11.5, E13.5, and E15.5
and to determine whether these hypoxic regions corresponded
to sites where defects arise in Cited2−/− embryonic hearts.
Examination of EF5 binding in the E11.5 hearts demonstrated
weak immunoreactivity in the myocardium at the rightatrioventricular junction of both wild-type and Cited2−/−
embryonic hearts (data not shown). At E13.5, before coronary
vasculature connects to aortic root (E14.5), the myocardium of
the OFT and IVS and atrioventricular cushion in both wild-type
(Figs. 2A, D) and Cited2-deficient (Figs. 2B, C, E, F) hearts was
similarly intensely immunopositive for EF5. In addition, there
was less intense but discrete EF5 immunopositivity within the
myocardium of the atrial and ventricular wall and atrioventri-
cular junction (Figs. 2D–F). By E15.5, after the coronary
vasculature connects to the aortic root, strong EF5 immunore-
activity in the myocardium of OFT, IVS, atrioventricular
junction, and ventricular wall and discrete EF5 immunoposi-
tivity in the myocardium of the atrial wall were still observed in
Cited2−/−;HIF-1α+/+ hearts (Figs. 2H, K). In contrast, the
immunoreactivity was dramatically reduced in both wild-type
(Fig. 2G) and Cited2−/−;HIF-1α+/− (Fig. 2I) hearts. The
atrioventricular junction of the wild-type (Fig. 2J) and the
IVS of Cited2−/−;HIF-1α+/− (Fig. 2L) hearts at E15.5 were
weakly but distinctly immunopositive for EF5. No EF5
immunopositivity within the myocardium of the interatrial
Fig. 2. Rescue of excessive hypoxia in the myocardium of the IVS in Cited2−/− embryos by HIF-1α haploinsufficiency. EF5 immunostaining in wild-type (A, D, G, J),
Cited2−/−;HIF-1α+/+ (B, E, H, K), and Cited2−/−;HIF-1α+/− (C, F, I, L) hearts. Sagittal (A–C, original magnification ×100) and transverse (D–F, original
magnification ×50) sections showed that the myocardium of OFT and IVS and atrioventricular cushion in wild-type (A, D), Cited2−/−;HIF-1α+/+ (B, E), and
Cited2−/−;HIF-1α+/− (C, F) hearts at E13.5 was similarly intensely immunopositive for EF5. Transverse sections (G–I, original magnification ×50) exhibited that
EF5 immunoreactivity was dramatically reduced in wild-type (G) and Cited2−/−;HIF-1α+/− (I) hearts but remained intense in the myocardium of OFT, IVS,
atrioventricular junction (AVJ), and ventricular wall in Cited2−/−;HIF-1α+/+ hearts at E15.5 (H). Higher magnifications of the IVS (J–L, original magnification
×100), showed that the AVJ in wild-type (J) and IVS in Cited2−/−;HIF-1α+/− hearts (L) were weakly but distinctly immunopositive for EF5.
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E11.5 and E15.5 (Figs. 2D–F; data not shown). Taken together,
these results show that the myocardium was hypoxic at the
stages of ventricular septum formation and hypoxia was most
severe in the OFT and IVS at E13.5 and dissipated by E15.5 in
the wild-type embryos. In contrast, Cited2-deficient hearts
remained highly hypoxic at E15.5 in these cardiac regions and
these cardiac regions were also consistently defective. Both the
severe hypoxia and cardiovascular defects were absent when the
gene dosage of HIF-1α was reduced in these Cited2-deficient
embryos (Fig. 2I).
HIF-1α nuclear localization in Wild-type,
Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− mouse
embryonic hearts
To demonstrate the physiological significance of the hypoxic
regions detected by EF5 during development, we examined the
expression of HIF-1α in wild-type, Cited2−/−;HIF-1α+/+, and
Cited2−/−;HIF-1α+/− embryonic hearts from the pregnant micethat were not injected with EF5. Interestingly, HIF-1α nuclear
localization was noted in almost the same regions that were
intensely EF5-immunopositive. At E13.5, the myocardium of
the OFT, IVS, atria, and ventricles of wild-type (Figs. 3A, D),
Cited2−/−;HIF-1α+/+ (Figs. 3B, E) as well as Cited2−/−;HIF-
1α+/− (Figs. 3C, F) hearts was immunopositive for HIF-1α
nuclear localization in a similar pattern. By E15.5, high HIF-
1α immunoreactivity in the OFT, IVS, and atrial and ventricular
wall was still observed in Cited2−/−;HIF-1α+/+ hearts (Figs. 3H,
K), but it was significantly reduced in both wild-type (Figs. 3G,
J) and Cited2−/−;HIF-1α+/− (Figs. 3I, L) hearts. The ventricular
wall of Cited2−/−;HIF-1α+/− heart (Fig. 3I) had relatively high
HIF-1α immunoreactivity in comparison to wild-type (Fig.
3G). Only low levels of HIF-1α immunopositivity in the atrial
walls of both wild-type (Fig. 3G) and Cited2−/−;HIF-1α+/−
(Fig. 3I) hearts and in the IVS of Cited2−/−;HIF-1α+/−
(Fig. 3L) hearts were detected at this stage. No HIF-1α
nuclear localization could be detected in spleen sections from 2
of each wild-type and Cited2−/− embryos at stages between
E13.5 and E16.5 (data not shown).
Fig. 3. Immunohistochemical detection of hypoxia. HIF-1α immunostaining on transverse sections from wild-type (A, G), Cited2−/−;HIF-1α+/+ (B, H), and Cited2−/−;
HIF-1α+/− (C, I) hearts. Panels D–F and J–L are higher magnifications of the boxed regions in panels A–C and G–I, respectively. The myocardium of OFT, IVS, atria,
and ventricles in wild-type (A, D), Cited2−/−;HIF-1α+/+ (B, E), and Cited2−/−;HIF-1α+/− (C, F) hearts at E13.5 was immunopositive for HIF-1α nuclear localization in
a similar pattern. High HIF-1α immunoreactivity was still observed in Cited2−/−;HIF-1α+/+ hearts at E15.5 (H, K), but it was significantly reduced in wild-type (G, J)
and Cited2−/−;HIF-1α+/− (I, L) hearts at E15.5. Red arrow: HIF-1α nuclear localization, white arrow: auto-fluorescent red blood cells.
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Cited2−/− embryonic hearts
One of the most potent responses to tissue hypoxia is the
induction of an angiogenic response in part mediated by the
expression of VEGF (Carmeliet and Collen, 2000). As shown in
Fig. 4a, HIF-1αmRNA levels in the E15.5 Cited2−/−;HIF-1α+/−
hearts were approximately half those of the wild-type and
Cited2−/−;HIF-1α+/+ hearts detected by real-time RT-PCR
(range, 0.4–0.6). VEGF-A and PGK1 mRNA levels in the
E15.5 Cited2−/−;HIF-1α+/+ hearts were 2.95- and 2.28-fold
higher than those in the wild-type hearts. Interestingly, VEGF-A
and PGK1 mRNA levels in the E15.5 Cited2−/−;HIF-1α+/−
hearts were reduced to 1.85-fold (1.32–2.39) and 1.19-fold
(1.01–1.38), respectively, compared with those in the wild-type
hearts, and were significantly lower than those in the E15.5
Cited2−/−;HIF-1α+/+ hearts (p=0.005 and p<0.001). VEGF-A
immunoreactivity in the IVS of E15.5 Cited2−/−;HIF-1α+/+
(Fig. 4b: H) hearts was also stronger than in wild-type (Fig.
4b: D) and Cited2−/−;HIF-1α+/− (Fig. 4b: L) hearts, suggesting
that VEGF-A up-regulation occurs selectively in regions of
relatively high levels of hypoxia in the ventricle and that HIF-1α heterozygosity reduced VEGF-A expression level in
Cited2−/− embryonic hearts.
HIF-1α heterozygosity rescued the defective myocardium and
abnormal coronary vasculature in Cited2−/− embryonic hearts
VEGF is essential for vasculogenesis and angiogenesis in the
embryo and fetus as well as for neovascularization of ischemic
tissues and tumors in the adult organism (Ferrara and Davis-
Smyth, 1997). CD31 immunohistochemistry, EBD staining,
measurement of the extravasation of EBD, and MF20
immunostaining were performed in 3 of each E15.5 wild-
type, Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− hearts to
investigate the coronary vascular and myocardium anomalies,
including 2 sets of wild-type, Cited2−/−;HIF-1α+/+, and
Cited2−/−;HIF-1α+/− littermate hearts. CD31 immunohistoche-
mistry demonstrated that capillary-sized vessels were replaced
by dilated sinusoidal vessels in E15.5 Cited2−/−;HIF-1α+/+
hearts (Figs. 5a: B, E), compared with normal capillary-sized
coronary vessels in E15.5 wild-type (Figs. 5a: A, D) and
Cited2−/−;HIF-1α+/− (Figs. 5a: C, F) hearts. In addition, as
shown in Fig. 5b, the coronary vascular permeability revealed by
Fig. 4. Molecular and histological analysis of wild-type, Cited2−/−;HIF-1α+/+, and Cited2−/−;HIF-1α+/− hearts. (a) Real-time RT-PCR was used to analyze relative
HIF-1α, VEGF-A, and PGK1 mRNA levels in the E15.5 Cited2−/−;HIF-1α+/+ and Cited2−/−;HIF-1α+/− ventricles, compared with those in wild-type ventricles.
n=5, n refers to number of animals per group; *p<0.01. (b) MF20 immunostaining of transverse sections from wild-type (A), Cited2−/−;HIF-1α+/+ (E), and
Cited2−/−;HIF-1α+/− (I) hearts at E15.5. Panels B–C, F–G, and J–K are higher magnifications of the boxed regions in panels A–C, respectively. The myocardium
of ventricular wall (F) and IVS (G) in Cited2−/−;HIF-1α+/+ hearts was significantly thinner than those in wild-type (B, C) and Cited2−/−;HIF-1α+/− (J, K) hearts.
VEGF-A immunohistochemistry on consecutive sections of panels A, E, and I showed that VEGF-A immunoreactivity in the myocardium of IVS in Cited2−/−;
HIF-1α+/+ (H) hearts was stronger than that in wild-type (D) and Cited2−/−;HIF-1α+/− (L) hearts (original magnification ×200).
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was 1.9-fold higher than that in wild-type embryonic hearts and
HIF-1α heterozygosity significantly decreased the coronary
vascular permeability in E15.5 Cited2−/− hearts (p=0.0083).
EBD staining revealed that large regions with EBD accumu-
lation were present in the IVS of E15.5 Cited2−/−;HIF-1α+/+
(Figs. 5c: B, C, F, G) hearts, compared to small regions in theIVS of E15.5wild-type (Figs. 5c: A, E) and Cited2−/−;HIF-1α+/−
(Figs. 5c: D, H) hearts. MF20 immunostaining showed that the
myocardium of the IVS and ventricular wall in E15.5 Cited2−/−;
HIF-1α+/+ (Figs. 4b: E–G) hearts was significantly thinner than
in E15.5 wild-type (Figs. 4b: A–C) and Cited2−/−;HIF-1α+/−
(Figs. 4b: I–K) hearts including the one with right atrial and
pulmonary isomerism. These results indicate that HIF-1α
Fig. 5. Rescue of abnormal coronary vasculature in Cited2−/− embryos by HIF-1α haploinsufficiency. (a) CD31 immunostaining on transverse sections from wild-type
(A), Cited2−/−;HIF-1α+/+ (B), and Cited2−/−;HIF-1α+/− (C) hearts at E15.5. Panels D–F are higher magnifications of the IVS regions in panels A–C, showing that
capillary-sized coronary vessels in wild-type (D) and Cited2−/−;HIF-1α+/− (F) hearts were replaced by dilated sinusoidal vessels in Cited2−/−;HIF-1α+/+ hearts (E).
(b) Embryos at E15.5 were injected with 10 mg/ml EBD in umbilical veins immediately after dissection. The coronary vascular permeability was assessed by
quantifying the extravasation of albumin-bound EBD in the embryonic ventricular tissue (μg EBD/mg dry tissue). n=3, n refers to the number of animals per
group; *p<0.01. (c) EBD staining on transverse sections fromwild-type (A), Cited2−/−;HIF-1α+/+ (B, C), and Cited2−/−;HIF-1α+/− (D) embryos at E15.5 after umbilical
venous dye injection. Panels E–H are higher magnifications of the boxed regions in panels A–D, showing that a larger region in the myocardium of IVS in Cited2−/−;
HIF-1α+/+ hearts (F, G) had accumulated EBD, compared with a small region in wild-type (E) and Cited2−/−;HIF-1α+/− (H) hearts. Arrow: EBD accumulation.
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myocardium of the OFT and IVS and the defective myocardium
in Cited2−/− embryonic hearts.
Discussion
Here we tested the hypothesis that some of the defects in
Cited2−/− embryos could be explained by abnormally high
levels of HIF-1 activity in the absence of this negative regulator
of HIF-1. By reducing the gene dosage of HIF-1α, we found
that malformations of the OFT, IVS, and spleen in Cited2−/−
embryos were largely rescued. In addition, we demonstrated
that Cited2-null hearts at E15.5 had abnormal coronary vessels,
persistence of myocardial hypoxia and HIF-1 nuclear localiza-
tion, and overexpression of HIF-1 regulated genes, which were
reduced or normalized by HIF-1α heterozygosity. These resultsstrongly suggest that an appropriate level of HIF-1 transcrip-
tional activity induced by differential microenvironmental
tissue hypoxia is critical for the normal development of the
myocardium and coronary vessels of the OFTand IVS of mouse
embryonic heart, and support a key role for Cited2 as a negative
regulator of HIF-1 activity in these regions.
Previous studies have shown that the myocardium of the
OFT and IVS is the most hypoxic area in the developing
chicken heart and that regional myocardial hypoxia is critical
for triggering the remodeling of the embryonic avian OFT
(Sugishita et al., 2004a,b; Wikenheiser et al., 2006). Disruption
of this hypoxia by exposure to hyperoxic conditions resulted in
OFT defects. These studies also revealed that the hypoxic
regions in the chicken embryo heart have HIF-1α accumulation
in the nuclei. The present study demonstrated that the OFT and
IVS of the mouse embryo have relatively high levels of
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during the normal course of cardiac septation and coronary
vascular development. HIF-1α is activated in response to
localized tissue hypoxia and global HIF-1α deficiency resulted
in developmental arrest and lethality by E11 of HIF-1α−/−
embryos that manifested neural tube defects, a single abnormal
pharyngeal arch, abnormal neural crest migration, and cardio-
vascular malformations (Iyer et al., 1998; Ryan et al., 1998;
Compernolle et al., 2003). Reducing HIF-1 transactivation
specifically in endothelial cells using the Flk-1 promoter to
induce endothelial cell-specific expression of the dominant
negative HIF-2α showed that HIF function is required in
endothelial cells for normal heart development (Licht et al.,
2005). Conditional knockout of HIF-1α from ventricular
cardiomyocytes using the mcl2v-cre resulted in a milder
phenotype but with a reduction in the coronary vasculature
and changes in heart function (Huang et al., 2004). These
studies point to an important role for specific regions of tissue
hypoxia and subsequent HIF-1 activation in the normal course
of cardiac development and coronary vessel formation.
As in most pathways, HIF-1 is negatively as well as
positively regulated. Cited2 has been shown to function as a
negative regulator of HIF-1 in vitro through its competitive
binding with HIF-1α to the transcriptional co-factors CBP/p300
(Bhattacharya et al., 1999). NMR structure analyses further
support the competition hypothesis by demonstrating that the
Cited2 transactivation domain disrupts the interaction between
the C-terminal transactivation domain of HIF-1α and the CH1
domain of CBP/p300 by binding to an overlapping binding site
on CH1 with higher affinity than the HIF-1α C-terminal
transactivation domain (Freedman et al., 2003). Furthermore,
transcript levels of HIF-1-responsive genes, Vegf, Glut1, and
Pgk1, in E14.5 Cited2−/− hearts (Yin et al., 2002) and mRNA
levels of VEGF-A and PGK1 in E15.5 Cited2−/− hearts in this
study (Fig. 4a) were 2- to 3-fold higher than those in wild-type
hearts. These data supported the role for Cited2 in modulating
HIF-1 activity in vitro and suggested that Cited2 plays this role
during heart development.
VEGF-A expression induced by HIF-1 in many cell types is
a potent component of the complex angiogenic response to
localized tissue hypoxia (Carmeliet and Collen, 2000). Over-
expression of VEGF-A in Cited2-null embryonic hearts may be
a major determinant for OFT and ventricular septum defects for
the following reasons. First, the most hypoxic regions of the
heart during development include the OFT and IVS (Fig. 2) that
are therefore likely to have a higher level of HIF-1α expression
and HIF-1 activity and in turn would increase downstream
VEGF-A expression. Second, 2- to 3-fold overexpression of
VEGF-A from the endogenous locus resulted in lethality of the
VEGF-A overexpressing embryos at E12.5 to E14 with severe
VSDs and abnormalities in the remodeling of the OFT
(Miquerol et al., 2000), which are similar to cardiac malforma-
tions in Cited2-deficient embryos (Supplemental Fig. 2).
Similar defects were observed in the avian embryos by the
injection of VEGF or by the overexpression of VEGF in the
OFT myocardium using adenoviral vectors (Feucht et al.,
1997; Sugishita et al., 2004b). Third, the most intenseexpression of VEGF-A was within the myocardium of the
OFT, IVS, and atrioventricular junction in the VEGF-A overex-
pressing mice (Miquerol et al., 2000), which is remarkably
similar to EF5 and HIF-1α immunostaining patterns. In the
present study, the VEGF-A protein level in the myocardium of
the IVS in the E15.5 Cited2−/−;HIF-1α+/+ hearts was higher than
that of wild-type and Cited2−/−;HIF-1α+/− hearts (Fig. 4b).
Finally, in the Cited2-null embryos, OFTand ventricular septum
defects were largely rescued when VEGF-A mRNA and protein
levels were decreased in heart tissues by HIF-1α haploinsuffi-
ciency (Fig. 1a).
Overexpression of VEGF-A in tumors led to formation of
structurally and functionally abnormal vessels that are leaky,
tortuous, dilated, and saccular and had a haphazard pattern of
interconnection while application of VEGF-A inhibitors
normalized tumor vasculature and improved perfusion (Jain,
2005). Injection of an adenoviral vector overexpressing
vascular permeability factor/VEGF164 also results in abnormal
vascularization with the formation of vascular glomeruloid
bodies in the ear skin of nude mice (Sundberg et al., 2001).
Similarly abnormal vasculature was observed within the
myocardium of the OFT and IVS in the Cited2−/− embryonic
hearts (Figs. 5a: B, E) and may be the consequence of
overexpression of VEGF-A in the myocardium. The rescue of
the coronary vasculature in the myocardium in the Cited2−/−;
HIF-1α+/− embryonic hearts where VEGF-A expression is re-
duced compared to the Cited2−/−;HIF-1α+/+ supports this
hypothesis (Figs. 5a: C, F). In addition, the abnormal persis-
tence of the myocardial hypoxia levels and defects of the OFT
and IVS in the E15.5 Cited2−/− hearts were also rescued by
HIF-1α heterozygosity. Thus, we propose that the increased
hypoxia of the OFT and IVS in Cited2−/−;HIF-1α+/+ versus
Cited2−/−;HIF-1α+/− hearts at E15.5, as indicated by more
intense EF5 and HIF-1α immunostaining, may be due to the
abnormally high VEGF-A expression levels in the Cited2−/−;
HIF-1α+/+ embryonic hearts resulting in higher permeability
of the coronary vessels and ineffective tissue perfusion
(Figs. 5b, c). In addition, the relatively high HIF-1α immuno-
reactivity in the ventricular wall in Cited2−/−;HIF-1α+/− versus
wild-type hearts at E15.5 may be explained by the relatively
high level of VEGF-A mRNA in Cited2−/−;HIF-1α+/− hearts.
Our results strongly suggest that differential myocardial
hypoxia and the proper level of HIF-1 activity are critical for
normal development of the OFT, IVS, and coronary vessels in
the mouse embryo. However, uncontrolled HIF-1 activity in the
absence of Cited2 is detrimental and results in abnormal
vasculature that can lead to persistent elevated hypoxia that
might contribute to further dysregulated HIF-1 activity.
In addition to the role for Cited2 as a negative regulator of
HIF-1 activity, Cited 2 serves other functions and the defects of
the Cited2 null may be the result of the misregulation of several
pathways that influence heart development. Tfap2, a transcrip-
tion factor necessary for neural tube and neural crest cell
development, interacts with Cited2 for its transcription
(Bamforth et al., 2001). In view of the multiple and profound
effects of the cardiac neural crest on cardiac development
(reviewed in Stoller and Epstein, 2005; Hutson and Kirby,
139B. Xu et al. / Developmental Biology 301 (2007) 130–1402003), it would be important to identify whether the absence of
Cited2 either directly or indirectly affects steps in neural crest
cell development. The typical cardiac defects associated with
neural crest cell defects such as persistent truncus arteriosus and
overriding aorta were observed in some of the Cited2−/− em-
bryos. However, muscular VSDs detected in Cited2-null em-
bryos are not typically associated with any models of neural
crest cell deficiency described so far (Hutson and Kirby, 2003).
In addition, there is little or no difference in the expression
patterns of neural crest markers, such as Crabp-1, Wnt-1,
Wnt-3, RXRα, and Pax3, between wild-type and Cited2-null
embryos (Barbera et al., 2002; Yin et al., 2002). Thus, a
deficiency in Tfap2 function and subsequent abnormalities in
neural crest cells does not appear to be the sole mechanism to
explain the full spectrum of cardiovascular defects in Cited2-
null embryos.
Laterality defects were reported in a proportion of Cited2-
null embryos with evidence that Cited2 is acting upstream of
Nodal, Lefty2, and Pitx2 in the lateral mesoderm and of
Lefty1 in the presumptive floor plate (Bamforth et al., 2004;
Weninger et al., 2005). A major function of the Pitx2c-
mediated left–right asymmetry pathway is to pattern the aortic
arches, OFT, and atrioventricular valves and cushions (Liu et
al., 2002; Franco and Campione, 2003). Since the Cited2-
Tfap2a/c complex regulates Pitx2c transcription and embryos
null for either Cited2 or Pitx2c develop similar cardiac defects
(Liu et al., 2002; Franco and Campione, 2003; Bamforth et al.,
2004), the role of Cited2 in establishing embryonic laterality
was suggested to explain the diverse cardiovascular mal-
formations in embryos lacking Cited2 (Bamforth et al., 2004).
However, 4 of 13 Cited2-deficient hearts displayed normal
Pitx2c expression in dorsal ventricular cells irrespective of
their laterality phenotype; 9 of 28 Cited2-null embryos did not
exhibit isomerism, but still developed a complex array of
cardiovascular defects (Weninger et al., 2005). In our study, all
12-coisogenic C57BL/6J Cited2−/− embryos had a wide
spectrum of cardiac defects, while only 7 of 12 Cited2−/−
embryos had left–right patterning defects. Therefore, some of
the cardiac malformations in Cited2−/− embryos may be
independent of left–right patterning defects.
Bamforth et al. (2004) further showed that the laterality
defects were significantly more frequent in Cited2−/− embryos
on the C57BL/6J background (7/11, 64%) than on the mixed
background (3/15, 20%), indicating that background-specific
genetic modifiers have an important role in determining the
left–right patterning defects. In their report, both the incidence
of the OFT (7/15, 47%) and ventricular septal (10/15, 67%)
defects in Cited2-null embryos on the mixed background and on
the C57BL/6J background (10/11, 91%) were much higher than
the incidence of the laterality defects, respectively, suggesting
that the OFT and ventricular septal defects in Cited2−/−
embryos, at least in part, are independent of the left–right
patterning defects. Moreover, Yin et al. (2002) reported that the
majority of Cited2−/− embryos (16/19, 84%) on the mixed
background had the OFT and ventricular septal defects and
Weninger et al. (2005) demonstrated that the incidence of the
OFT (21/24, 87%) and ventricular septal defects (22/24, 92%)in Cited2-null embryos on the mixed background was
extremely high. These results support that, unlike the laterality
defects, the incidence of OFT and ventricular septal defects in
Cited2−/− embryos is not significantly modified by genetic
background.
In conclusion, our results establish an essential role for
Cited2 in the development of the OFT and IVS of mouse
embryonic heart by down-regulating the HIF-1 regulated
hypoxia response. The absence of this regulatory function
provides a mechanism to explain malformations of the OFT,
IVS, and spleen in Cited2-deficient embryos in the absence of
laterality defects. Interestingly, a recent study by Sperling et al.
(2005) reported three functionally relevant mutations of Cited2
in 392 patients with congenital heart defects. All of these
mutations significantly reduced the capacity of Cited2 to
transrepress HIF-1α with one also resulting in significantly
diminished Tfap2c co-activation. The importance of embryonic
hypoxia has long been recognized as an environmental risk
factor of congenital heart defects. To date, however, the
mechanism by which prenatal hypoxia contributes to congenital
heart defects has not been established. The Cited2 knockout
mouse in combination with other mouse lines may serve as
useful models to investigate the molecular mechanism by which
hypoxia regulates critical events in normal and abnormal
embryonic heart development. These studies may also provide
potential therapeutic strategies in treating patients with
congenital heart defects.
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